Rossella Belleli

Rapid and robust response of biochemical markers of bone formation to teriparatide therapy

Sarah Glover, Richard Eastell, Eugène McCloskey et al. · Bone · 2009 · 176 citations

Medicine, Pharmacokinetics, Pharmacology +15

Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major.

Renzo Galanello, Antonio Piga, Yves Bertrand et al. · PubMed · 2006 · 139 citations

Medicine, Hematology, Pharmacology +17

ATF936, a novel oral calcilytic, increases bone mineral density in rats and transiently releases parathyroid hormone in humans

Markus R. John, Leo Widler, R. Gamse et al. · Bone · 2011 · 49 citations

Medicine, Endocrinology, Oral Biology +12

Effect of Food, Type of Food, and Time of Food Intake on Deferasirox Bioavailability: Recommendations for an Optimal Deferasirox Administration Regimen

Renzo Galanello, Antonio Piga, Maria Domenica Cappellini et al. · The Journal of Clinical Pharmacology · 2008 · 43 citations

Agriculture, Nutritional Sciences, Pharmacology +17

AXT914 a novel, orally-active parathyroid hormone-releasing drug in two early studies of healthy volunteers and postmenopausal women

Markus R. John, Evita Harfst, Juergen Loeffler et al. · Bone · 2014 · 37 citations

Medicine, Endocrinology, Pharmacology +7